Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-24-001840

Chief Financial Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Chief Financial Officer 2024-01-16 Grant or award +200,000 343,851 D
Loading xslF345X05/doc4.xml…